Key Facts

Invested since 2012
Based in Thuringia

About the company

JeNaCell produces biotechnologically generated nanocellulose (BNC) in an IP protected, continuous and automated production process: high quality innovative products for applications in medicine, cosmetics and more.

Do you want to

know more about this company?

JeNaCell in the news

Zum Artikel

News

2. August 2021

Successful exit for High-Tech Gründerfonds – HTGF fund investor Evonik acquires biotech company JeNaCell

Zum Artikel

Press

9. July 2015

Additional financing for JeNaCell: Investors once again back platform technology for the production of high-tech bio-material

Zum Artikel

Press

12. October 2012

JeNaCell Receives Seed Financing from High-Tech Gründerfonds and STIFT